Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
---|
03/09/2000 | WO2000012462A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
03/09/2000 | WO2000012089A1 Novel angiogenesis inhibitors |
03/09/2000 | WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
03/09/2000 | DE19942897A1 A process for the preparation of 2-alkyl-4-oxocycloheptimidazoles and their salts, by treating a 3-methoxy-2-halocycloheptenone with alkylamidine hydrochloride, useful as intermediates for angiotensin II receptor antagonists |
03/09/2000 | CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
03/09/2000 | CA2341458A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
03/09/2000 | CA2341409A1 Novel angiogenesis inhibitors |
03/08/2000 | EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
03/08/2000 | EP0983263A1 Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
03/08/2000 | EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds |
03/08/2000 | EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
03/08/2000 | EP0854857B1 Method of preparing optically active alpha-amino acids and alpha-amino acid derivatives |
03/08/2000 | CN1050122C Benzimidazoles, pharmaceutical compositions containing these compounds and process for preparing them |
03/07/2000 | US6034116 Mixtures of substituted benzimidazoles with polyether antibiotics or synthetic coccidiostats as agents for use against parasitic protozoa |
03/07/2000 | US6034115 Indolyl-substituted phenylacetic acid derivatives |
03/02/2000 | WO1999064054A9 Multibinding inhibitors of topoisomerase |
03/02/2000 | WO1999063937A3 Multivalent macrolide antibiotics |
03/01/2000 | EP0513387B1 Thiazole derivatives as active oxygen inhibitors |
02/29/2000 | US6030629 Photoprotective cosmetic/dermatological compositions comprising synergistic admixture of sunscreen compounds |
02/24/2000 | WO2000009498A1 Prodrugs of proton pump inhibitors |
02/24/2000 | WO2000009116A1 Grp receptor ligands |
02/23/2000 | EP0980359A1 Benzimidazole derivative |
02/23/2000 | CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity |
02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
02/22/2000 | CA2170607C Difluoro statone antiviral analogs |
02/17/2000 | WO2000008014A1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
02/17/2000 | DE19834325A1 New benzo-condensed heterocyclic compounds useful in treatment of thrombosis and prevention of vascular occlusion |
02/15/2000 | US6025398 Benzamidoxime prodrugs as antipneumocystic agents |
02/15/2000 | US6025379 Methods of treating or preventing interstitial cystitis |
02/15/2000 | US6025378 Antiatherosclerotic action. |
02/10/2000 | WO2000006585A1 Medicine nitrate salts |
02/10/2000 | WO2000006573A1 Antiviral alkyl substituted purine derivatives and their preparation |
02/10/2000 | WO2000006545A1 High affinity ligands for nociceptin receptor orl-1 |
02/10/2000 | WO2000006529A1 Diketoacid-derivatives as inhibitors of polymerases |
02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
02/10/2000 | WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2 |
02/10/2000 | CA2338912A1 Medicine nitrate salts |
02/10/2000 | CA2338490A1 Diketoacid-derivatives as inhibitors of polymerases |
02/09/2000 | EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments |
02/09/2000 | EP0978392A1 Optical recording media |
02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
02/09/2000 | CN1244193A Novel amide derivatives and medicinal compositions thereof |
02/08/2000 | US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
02/08/2000 | US6022978 Benzimidazole derivatives |
02/08/2000 | US6022872 α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
02/03/2000 | WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
02/03/2000 | WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein |
02/03/2000 | DE19834751A1 Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel Disubstituted bicyclic heterocycles, their preparation and their use as medicaments |
02/03/2000 | DE19833853A1 Verfahren zur Herstellung von Aminosäuren und Aminosäurederivaten A process for the production of amino acids and amino acid derivatives |
02/03/2000 | CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
02/02/2000 | EP0976721A2 Process for the preparation of amino acids and amino acid derivatives |
02/01/2000 | US6020354 Fungicides, bactericides |
02/01/2000 | US6020342 Fused imidazo[1,2-A]pyridines |
02/01/2000 | CA2195064C Amino-acid amide derivatives, processes for preparing the same, agricultural or horticultural fungicides, and method for killing fungi |
01/27/2000 | WO2000003997A1 Thiobenzimidazole derivatives |
01/27/2000 | WO2000003973A1 Diacylhydrazine derivatives as integrin inhibitors |
01/27/2000 | WO2000003709A1 Novel dna-cleaving antitumor agents |
01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
01/27/2000 | CA2337517A1 Novel dna-cleaving antitumor agents |
01/27/2000 | CA2337305A1 Diacylhydrazine derivatives |
01/26/2000 | EP0974336A2 Composition for oxidative dying of keratinous fibres and dying process therewith |
01/26/2000 | EP0973750A1 Substituted benzimidazoles and their use for treating retroviral infection |
01/26/2000 | EP0973749A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists |
01/26/2000 | EP0973513A1 Compositions and methods for treating bone deficit conditions |
01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
01/26/2000 | EP0973396A1 A method of treating cancer |
01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
01/25/2000 | US6018052 Fungicidal optically active 1-(mono-or substituted amino)-2-substituted-4,4-disubstituted-2-imidazolin-5-ones and 5- thiones corresponding |
01/25/2000 | US6018050 Enantiomerically pure compounds obtained in high yields; preparing sterically demanding amino acids and their derivatives, such as the preparation of cis-4-hydroxyproline precursors; asymmetric synthesis |
01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
01/20/2000 | WO2000002876A1 Improved process of synthesis of 5-methoxy- 2-[(4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl]sulfinyl-1h-benzimidazole |
01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
01/20/2000 | WO1999058518A3 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
01/20/2000 | DE19831710A1 New diacyl-hydrazine derivatives, are integrin inhibitors useful for treating e.g. thrombosis, cardiac infarction, tumors, osteoporosis, inflammation or infection |
01/19/2000 | EP0972769A1 Novel amide derivatives and medicinal compositions thereof |
01/19/2000 | EP0971920A1 Compounds for inhibition of gastric acid secretion |
01/19/2000 | EP0971909A1 Lta 4? hydrolase inhibitors |
01/19/2000 | CN1242006A Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
01/19/2000 | CN1242001A Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
01/19/2000 | CN1241563A Method of synthesizing benzimidazole and its derivative |
01/19/2000 | CN1048486C Method for preparing benzimidazole derivatives |
01/13/2000 | WO2000001704A2 Benzimidazoles, production thereof and use thereof as medicaments |
01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
01/13/2000 | WO2000001675A1 Novel benzimidazoles as corticotropin release factor antagonists |
01/13/2000 | WO2000001666A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
01/13/2000 | WO2000001389A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
01/13/2000 | WO2000001383A1 Angiogenesis inhibitors |
01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
01/13/2000 | DE19830430A1 New sulfur-substituted sulfonylamino-carboxylic acid N-arylamide derivatives useful as guanylate cyclase activators in treatment of e.g. cardiovascular disorders, asthma and diabetes |
01/13/2000 | CA2336774A1 Angiogenesis inhibitors |
01/13/2000 | CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
01/13/2000 | CA2335779A1 Novel benzimidazoles as corticotropin release factor antagonists |
01/12/2000 | EP0970082A2 Biazacyclic crf antagonists |
01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
01/12/2000 | EP0969819A2 New crystalline form of omeprazole |
01/06/2000 | WO2000000476A1 Process for preparing oximidazoles |
01/05/2000 | EP0968250A1 Soluble chromophores having improved solubilising groups |